Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
复制标题
1 型糖尿病儿童持续皮下胰岛素输注 (CSII)。
DOI：
10.1016/s0168-8227(06)70011-0
复制
发表时间：
2006
影响因子：
5.1
通讯作者：
Weinzimer,StuartA
中科院分区：
文献类型：
--
作者：
Tamborlane,WilliamV;Sikes,KristinA;Steffen,AmyT;Weinzimer,StuartA
Recent studies have shown that continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, provides a treatment option that can assist in the attainment of current goals of treatment in children and adolescents with type 1 diabetes (T1DM). In pediatric patients, CSII has been demonstrated to reduce both glycosylated hemoglobin levels and frequency of severe hypoglycemia, without sacrifices in safety, quality of life, or excessive weight gain, particularly in conjunction with the use of new insulin analogs and improvements in pump technology. Clinical studies of safety and efficacy of CSII in children are reviewed.
